MICHELLE SNOW: Open Payments
NPI 1699317438 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 31 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $195 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $186 |
| Boston Scientific Corporation | 5 | $129 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Amgen Inc. | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| PFIZER INC. | 2 | $46 |
| BridgeBio Pharma, Inc. | 2 | $41 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
Products named: JARDIANCE, WATCHMAN FLX, ONPATTRO, REPATHA, LEQVIO, Attruby, FUROSCIX, VYNDAQEL.
Industry payments across MI — which companies pay providers there.
